| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2881528 | The Annals of Thoracic Surgery | 2007 | 9 Pages |
Abstract
Greater use of indicated secondary prevention medications after coronary artery bypass graft surgery is associated with a lower 2-year rate of death or myocardial infarction. These data underscore the importance of appropriate secondary prevention measures to improve long-term clinical outcomes after coronary artery bypass graft surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abhinav MD, MHS, John H. MD, MHS, Gail E. MS, Stacy H. MD, Rajendra H. MD, MS, Michael J. MD, Randall K. MD, Lawrence H. MD, Nicholas T. MD, Robert A. MD, Daniel MD, C. Michael MD, Robert M. MD, T. Bruce MD, Eric D. MD, MPH,